MGMT and glioma: At present, prognostic indicators of gliomas include clinicopathological features, such as Ki67,3, 4 IDH,5, 6, 7 MGMT promoter methylation (MGMT‐PM),8, 9 and 1p/19q co‐deletion.7, 10, 11